Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer - Haas, Rainer; Schmid, Hans; Hahn, Uwe; Hohaus, Stefan; Goldschmidt, Hartmut; Murea, S.; Kaufmann, Manfred; Wannenmacher, Michael; Wallwiener, Diethelm; Bastert, Gunther; Hunstein, Werner (European journal of cancer, 1997)
Elektronische Reproduktion der Druck-Ausgabe 22. Juli 2002